Partnership & Donor Packages

Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

The company has 31 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The Company’s robust product portfolio is spread over 7 major therapeutic/product areas encompassing CNS, Anti-Retroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.

Aurobindo Pharma’s ARV mission is to provide a wide, high-quality antiretroviral drugs (USFDA Approved) for PLHIV & CLHIV with high accessibility at affordable prices. In order to contribute to UNAIDS ambitious goal of achieving 95-95-95 by 2030, Aurobindo Pharma is expanding through state-of-the-art manufacturing facilities and currently providing latest treatment options to more than 3 million PLHIV & CLHIV with its antiretroviral drugs.

Atlantic Lifesciences Ltd. (ALS) is a leading sterile pharmaceutical and biopharmaceutical manufacturer in Ghana, producing infusions, ophthalmics, biologics, vaccines, and inhalational anaesthetics under WHO GMP standards, with over 500 employees. Established in 2017, ALS operates one of West Africa’s largest pharmaceutical manufacturing facilities, with an annual installed capacity of 66 million infusion bottles and 70 million eye drops, exporting across the ECOWAS sub-region. ALS is the first company in Ghana to set up a multiple vaccine fill-finish plant (150 million doses/year), supporting the AU’s goal of 60% vaccine self-sufficiency by 2040 in Africa. Led by CEO, Mr. Dhananjay Tripathi, ALS is committed to affordable, high-quality healthcare solutions.

The Aurum Institute is a proudly African organisation dedicated to improving health and wellbeing through innovation in global health research and implementation. Guided by our vision of creating a healthier world for future generations, we generate evidence that informs policy and translate policy into practice to strengthen health systems and improve access to care.

With more than two decades of experience in TB and HIV prevention, care and treatment, Aurum also leads high-impact programmes and research in non-communicable diseases (NCDs), COVID-19, digital health, and broader health systems strengthening. Our work spans implementation science, community and facility-based interventions, and large-scale partnerships with governments, donors, researchers and communities across Africa and beyond.

Rooted in our mission and values of Excellence, Innovation, Integrity, Respect and Teamwork, Aurum continues to contribute to South Africa’s HIV response and the global goal of ending AIDS.

bioLytical Laboratories Inc. is a global leader in rapid in vitro diagnostic tests. Our one-minute INSTI® tests deliver fast, accurate results for infectious diseases like HIV, Syphilis, and HCV. By detecting specific antibodies, INSTI® ensures reliable diagnosis in just 60 seconds. Expanding accessibility, iStatis introduces high-quality rapid testing, starting with COVID-19 Antigen detection. Designed for ease of use, iStatis reaches people wherever they are. Together, INSTI® and iStatis break barriers to testing, ensuring more individuals can quickly learn their status. With innovation and accessibility at our core, bioLytical is transforming global healthcare through faster, more effective disease detection.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (Wantai Biopharm) is a Beijing-based high-tech company, founded in 1991, specializing in R&D and production of diagnostics and vaccines. It was listed on the Shanghai Stock Exchange in 2022 with a market cap of around $15 billion. A significant milestone was achieved in 2025, the cutting-edge product HIV urine-based self-test prequalified by WHO, enhancing global access to discreet and convenient HIV screening.

Founded in 1992, BIONEER is Korea’s first biotech company dedicated to advancing global public health through next-generation molecular diagnostics. With over 500 global patents, we have developed innovative solutions spanning sample preparation, PCR reagents, and fully automated molecular diagnostic systems. BIONEER became the first in Asia to obtain WHO prequalification for an HIV-1 Viral Load test and offers a comprehensive portfolio covering diagnostics for Tuberculosis (TB) and other high-risk infectious diseases. We continue to empower researchers and healthcare professionals worldwide with reliable, accessible, and cutting-edge molecular diagnostic tools for better disease management.

Bruker offers complete solutions in microbiology and diagnostics: in vitro diagnostic tests, instrumentation, training, maintenance; with applications for HIV, hepatitis, STI, TB and mycobacteria, gastrointestinal infections…

For over 20 years, Bruker has been Africa's partner in the fight against AIDS and viral hepatitis, and other chronic and emerging infectious diseases.

Bruker collaborates actively with National HIV Programs, NGOs, Reference Centers and Ministries of Health to support healthcare professionals in patient management.

GenBody is dedicated to pioneering innovative solutions in the field of In Vitro Diagnostics (IVD). Our offerings include comprehensive diagnostic solutions, such as rapid diagnostic tests (RDTs) and clinical chemistry. With over 20 years of experience in the diagnostic industry, our core strength lies in research and development. Notably, we specialize in developing monoclonal antibodies and recombinant antigens in-house at our facility in South Korea. Building on our expertise in rapid test technology, we continuously develop innovative products, such as ConfiSign Self-Test series, using VFRT(Vertical Flow Rapid Test) technology, which enables testing for HIV, HIV/Syphilis, and HCV.

HUMAN has been a trusted name in the IVD industry for over 50 years, offering an extensive portfolio that spans classical clinical chemistry, molecular diagnostics, and specialized autoimmunity assays. With strong global service, reliable logistics, and a long-standing distributor network, we support laboratories worldwide and partner with governmental and non-governmental organizations. Present in more than 160 countries, HUMAN products are developed in Germany to the highest quality standards and designed to meet the needs of diverse global healthcare environments. Dedicated to sustainability, we emphasize environmental responsibility to ensure a future-oriented, reliable, and ethical approach to diagnostics

Healgen Scientific develops, manufactures and commercialises in vitro diagnostic test systems worldwide with a product portfolio that spans multiple testing categories and analytes to meet a range of clinical and laboratory needs. Healgen’s testing platforms include rapid testing, molecular diagnostics, multiplex flow cytometry and the VISITECT® Advanced Disease test, a unique, rapid, instrument-free, semi-quantitative lateral flow assay for the identification of Advanced HIV Disease in decentralised settings. Healgen currently supplies products in more than 120 countries including the United States, Europe, Africa, South Asia, the Middle East and Latin America.

Hetero is a global pharmaceutical company headquartered in Hyderabad, India, with over 30 years of excellence in advancing access to quality healthcare. As one of the world’s largest producers of APIs, Hetero operates 36+ world-class facilities, including 7 international manufacturing sites for APIs, FDFs, and Biosimilars. A global leader in ARV APIs and formulations, Hetero supplies over 40% of HIV/AIDS treatments through collaborations with global procurement agencies and pharma partners. With a presence in 145+ countries and backed by 30,000+ professionals worldwide, Hetero is committed to expanding access to affordable healthcare and advancing long-acting injectables for HIV prevention.

IAS – the International AIDS Society – convenes, educates and advocates for a world in which HIV no longer presents a threat to public health and individual well-being. After the emergence of HIV and AIDS, concerned scientists created the IAS to bring together experts from across the world and disciplines to promote a concerted HIV response.

Today, the IAS and its members unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all those living with and affected by HIV.

The IAS also hosts the world’s most prestigious HIV conferences: the International AIDS Conference, the IAS Conference on HIV Science and the HIV Research for Prevention Conference

InTec is a world leading manufacturer in infectious disease diagnostics focusing on screening at the Point of Care. In past 34 years we have focused on rapid diagnostics for infectious diseases and other tests for low resourced settings. InTec has a good reputation globally for quality and performance. We have focused on quality products and ensure all certifications are in place. InTec obtained the WHO Pre-Qualification for HIV and HCV rapid tests in 2019, and continually supports NGOs globally. We are a global leader in HIV and Hepatitis screening, and are dedicated to the continued development of innovative testing.

IMMY brings rapid, high-quality fungal diagnostics closer to the patient. We deliver accurate and affordable solutions that can be implemented in any laboratory setting around the world. IMMY is bridging the gap between fungal infections and proper treatment through rapid diagnostics for Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, and Blastomycosis.

With over 35 years of manufacturing experience in the healthcare industry, Karex is known as the World's Largest Condom Manufacturer with the ability to produce more than 5 billion pieces of condoms annually. Its other offerings include Personal Lubricants, Latex & non-latex Probe Covers, Foley Balloon Catheters, Nitrile condoms & Oral Dams. With over 3000 employees and four advanced manufacturing facilities in Malaysia and Thailand, Karex conforms to major international standards and holds various global certifications to qualify us for exports to more than 140 countries. Karex’s sales and distribution channels are also supported by offices located in the UK, U.S.A., Thailand and Malaysia.

We welcome you to know more about our products and visit us at Booth number 21

KELIN is a human rights organization founded in 1994 to promote a rights-based approach to health. Originally focused on HIV, law, and human rights, it now addresses sexual and reproductive health, women’s land rights, strategic litigation, and health governance. Through policy engagement, litigation, community empowerment, research, and advocacy, KELIN advances the right to health in Kenya, with regional and global interventions.

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company dedicated to improving the quality of life for millions around the world.

Laurus has established a global leadership position in the development and manufacturing of select Active Pharmaceutical Ingredients (APIs) & Finished Dosage Form (FDF), including those for anti-retroviral (ARV), oncology, cardiovascular, and gastro therapeutics.

This expertise, paired with backward-integration capabilities and rigorous quality standards, has enabled Laurus to build a solid reputation across the pharmaceutical industry for high-quality, innovative products.

The Medicines Patent Pool (MPP) is a UN-backed international public health organisation dedicated to increasing access to essential medicines and health technologies in low- and middle-income countries. MPP works with partners to license these medicines and technologies through its innovative business model, encouraging the development of new formulations and the expansion of generic manufacturing markets.”

Founded in 2006, Meril is a global medical device company located in India, Meril was launched in line with the healthcare diversification plan for global healthcare. Today, Meril is a global medical device company (distributing in over 120 countries) dedicated to the design and development of novel clinically relevant, state-of-the-art and best-in-class devices to alleviate human suffering and improve quality of life. We span a broad operational canvas ranging from Vascular Interventions, Orthopedics, Robotics, Endo-Surgery, In-vitro-Diagnostics & ENT.

We have RDTs in our product portfolio which are WHO PQ including HIV RDT, Malaria Pf HRP-II RDT, Malaria Pf/Pan RDT & Malaria Pf/Pv RDT. Also, we have COVID-19 rapid antigen as well as antibody tests with CE approval in place.

Headquartered in India with a manpower of more than 13000, Meril currently conducts business in more than 120 countries. We have 100% subsidiaries in more the 30 countries including the USA, Germany, Brazil, Russia, South Africa, Bangladesh, Malaysia and Turkey.

Crée en 1980, Médecins du Monde est une association médicale militante de solidarité internationale qui défend un système de santé juste et universel. Elle soigne, interpelle et plaide, en France et à l’international, pour garantir l’accès aux soins des populations vulnérables. Son engagement va au-delà des actes médicaux : écouter, accompagner, protéger, former et dénoncer les atteintes aux droits humains. Avec ses partenaires et les communautés concernées, elle agit localement et durablement pour lutter contre la discrimination et améliorer les politiques de santé. Parce que sans santé, il n’y a pas d’avenir.

MSD’s Commitment to HIV For more than 35 years, MSD has been committed to scientific research and discovery in HIV. Today, we are developing a series of antiviral options designed to help people manage HIV and protect people from HIV, with the goal of reducing the growing burden of infection worldwide. We remain committed to collaborating with others in the global HIV community to address the complex challenges that impede progress toward ending the epidemic.

The National AIDS/STI Control Programme (NACP) is a Ghana Health Service unit under the Disease Control and Prevention Department of the Public Health Division. It began in 1987, evolving from the National Technical Committee on AIDS and the National Advisory Council on HIV and AIDS. Since then, NACP has led the health sector’s response to HIV and AIDS in Ghana. The Programme oversees the implementation of the health sector components of the National HIV and AIDS Strategic Plan (2021–2025), guided by the Health Sector Programme of Work and the HIV Strategic Framework. NACP is mandated to deliver interventions to prevent new HIV infections, provide treatment, care, and support for people living with HIV, generate strategic information for decision-making, and offer technical support to other sectors. Through innovation, collaboration, and community partnerships, NACP continues to drive Ghana’s efforts toward achieving the 95-95-95 targets and ending AIDS as a public health threat by 2030.

OraSure Technologies, Inc. transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality and value of healthcare with innovation in effortless tests and sample collection solutions.

OraSure, together with its subsidiaries, DNA Genotek and Sherlock Biosciences, is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection, and stabilization devices designed to discover and detect critical medical conditions.

SD BIOSENSOR is an in-vitro diagnostics company that contributes to improving the quality of life by quickly and accurately diagnosing diseases under the slogan ‘Beginning of all things that protect lives’. Our IVD portfolio has expanded from immune-based IVD to POC Molecular Diagnostics, including over 190 diagnostic products. The headquarters of SD BIOSENSOR is located in Korea and the subsidiaries are located in India, Indonesia, Brazil, Germany, Italy, USA, Panama, Spain and Colombia. SD BIOSENSOR will continuously create new values by analyzing data using AI technology as well as by offering accurate, innovative and effective diagnostics to contributing human health.

The Society for AIDS in Africa (SAA) was established in Kinshasa in October 1990 during the 5th International Conference on AIDS and Associated Cancers in Africa, a precursor to the International Conference on AIDS and STIs in Africa (ICASA).

The formation of SAA with the support of the World Health Organization (WHO) brought to an end, the practice of organizing the International Conference on AIDS in Africa, outside the African continent. At the same time, it empowered Africans to address and respond to the challenges posed by HIV/AIDS on the continent.

The SAA envisions an HIV free Africa with capacity to confront HIV/AIDS and its consequences as well as its related diseases (such as Tuberculosis and Malaria).

The Society also promotes positive environment and research on HIV and its related diseases. The SAA is governed by an Executive Council drawn from South, North, East, West and Central Africa.

SAA partners and collaborates with range of NGOs and it enjoys the support of the UN-System, as well as various International organizations, including the International AIDS Society (IAS). The Society for AIDS in Africa, is the organizer of ICASA. The next ICASA will be organized in 2027. The host country will be announced soon.

The Paediatric-Adolescent & Treatment Africa (PATA) is an action network of frontline healthcare providers (FHP) working in partnership with communities. The network is dedicated to improving access to HIV, child/adolescent health, and sexual reproductive health services. We want to connect, motivate, and empower like-minded champions for health, rights and service quality for children, adolescents, youth, and caregivers affected by HIV in Africa.

Pro-link is a non-governmental organization founded in 1993 and operates in 10 regions Ghana. The organisation currently has 5 permanent offices and 17 project offices with its headquarters in Accra.

Its mission is to “To empower and advocate with disadvantaged people (especially women and girls) to uphold their human rights and improve on their health, education, socio-economic status.”

Pro-link has significantly contributed to HIV intervention programs in Ghana by forming 8 community and faith-based organizations to support people living with HIV.

Prolink has implemented various projects, including SHARP, SHARPER, LINKAGES, Gender and HIV project, HIV intervention for key population and vulnerable groups, Care continuum project with support from USAID,GAC/ Danida, FHI360, JSI etc.

The organization’s unique capacity, project management experience, experienced staff, professionalism and financial systems make it a valuable partner in the fight against HIV in Ghana.

Founded in 2017, Pluslife develops, manufactures, and commercializes molecular diagnostics for real-world care. Built on its proprietary RHAM isothermal technology, the MiniDock platform and multiplex test cards deliver PCR-comparable performance with minimal hands-on time in decentralized settings. The portfolio spans TB, respiratory, STIs, and veterinary uses, with deployments in 40+ countries. Pluslife's MiniDock MTB was ERPD-listed in July 2025. To support broader adoption, Pluslife is conducting a multi-center clinical study across more than 10 low- and middle-income countries, covering over 10,000 samples. Pluslife also holds 190+ patents/certifications (60+ granted patents, 130+ approvals).

Headquartered in Nairobi, Kenya, PAAL is dedicated to enhancing access to healthcare across Africa by bridging the gap between public, private, and the NGO/FBO sector.

Our Mission
PAAL is dedicated to removing barriers and paving the way for universal access to quality healthcare. We are rooted in the belief that access to quality health is a fundamental human right, and our commitment to every individual, regardless of circumstance, is entitled to quality healthcare in pursuit of the SDG 3: Good Health and Well-being.

Our Vision
We hope to transform access to healthcare on a global scale. We believe in integrity, partnership, transparency, efficiency, honesty, and value for money. We aim to maximize impact and achieve our mission by leveraging on the SDG 9: Industry, Innovation, and Infrastructure.

The Global Fund invests up to US$5 billion a year to defeat HIV, TB and malaria and ensure a healthier, safer, more equitable future for all.

We unite the world to find solutions that have the most impact, and we take them to scale worldwide. It’s working. We won’t stop until the job is finished.

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. #EndAIDS

Viatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases.

We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and connect with us on LinkedIn, Instagram, YouTube and X.

ViiV Healthcare is a specialist pharmaceutical company 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS. At ViiV Healthcare we do things differently. From our unique origins to our innovative medicines, we push the boundaries of what people think is possible in HIV treatment and care. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, at ViiV Healthcare we are determined to help end the HIV epidemic. Our one focused goal unites our employees located across the globe, with their expertise in research, manufacturing, policy and more, all guided by our mission to be here until HIV isn’t.

Wondfo, founded in 1992 and headquartered in Guangzhou, China, is a trusted provider of in vitro diagnostic (IVD) solutions with global reach. Beyond advancing technology, we are dedicated to people—committed to improving global health outcomes and creating shared value for our employees, customers, and partners.

With strong R&D capabilities across nine technology platforms, our products support rapid testing and chronic disease management in over 150 countries and regions. Guided by our vision “Racing for Life”, we are committed to advancing diagnostics through continuous innovation, striving for excellence and building trust through every solution we deliver.

The WHO Regional Office for Africa (WHO AFRO) is one of six regional offices of the World Health Organization, serving 47 Member States across the African continent. Headquartered in Brazzaville, Republic of Congo, WHO AFRO works with governments and partners to improve health outcomes through technical support, policy guidance, and coordination of health initiatives. Its work spans disease prevention and control, health systems strengthening, emergency preparedness and response, and promoting universal health coverage. WHO AFRO translates global health priorities into regional action, ensuring that every person in Africa has access to quality, affordable health care without financial hardship.